Evidence map›Paper›PMID 26468539›Full record

ArticleJournal of virology2016

Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.

Georges Abboud, Vikas Tahiliani, Pritesh Desai, Kyle Varkoly, John Driver, Tarun E Hutchinson, Shahram Salek-Ardakani

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 65 citations in OpenAlex.

  1. Immune cell disorder in viral pneumonia.Journal of translational medicine · 2026
    Review
  2. A temporal and spatial atlas of adaptive immune responses in the lymph node following viral infection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Poxviridae Pneumonia.Advances in experimental medicine and biology · 2024
    Review
  10. Review
  11. Review
  12. Article
  13. CD16American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. The Lanostane Triterpenoids inLife (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Georges AbboudDepartment of Pathology, Immunology & Laboratory Medicine, University of Florida, Gainesville, Florida, USA.
Vikas TahilianiDepartment of Pathology, Immunology & Laboratory Medicine, University of Florida, Gainesville, Florida, USA.
Pritesh DesaiDepartment of Pathology, Immunology & Laboratory Medicine, University of Florida, Gainesville, Florida, USA.
Kyle VarkolyDepartment of Pathology, Immunology & Laboratory Medicine, University of Florida, Gainesville, Florida, USA.
John DriverDepartment of Pathology, Immunology & Laboratory Medicine, University of Florida, Gainesville, Florida, USA.
Tarun E HutchinsonDepartment of Pathology, Immunology & Laboratory Medicine, University of Florida, Gainesville, Florida, USA.
Shahram Salek-ArdakaniDepartment of Pathology, Immunology & Laboratory Medicine, University of Florida, Gainesville, Florida, USA ssalek@ufl.edu.
University of Florida · US

Funding

IMMUNOLOGIC/GENETIC MECHANISMS IN RHEUMATIC DISEASEST32AR007603 · NIAMS · UNIVERSITY OF FLORIDA · PI REEVES, WESTLEY H · 1998 to 2014
$2.2M
LIGHT_HVEM_BTLA axis in protective anti_viral immunityR01AI087734 · NIAID · UNIVERSITY OF FLORIDA · PI SALEK-ARDAKANI, SHAHRAM · 2011 to 2015
$1.6M
Intramural NIH HHSNIAID NIH HHS AI087734NIAID NIH HHS HHSN272201300006CNIAID NIH HHS R01 AI087734NIAMS NIH HHS T32 AR007603NIAMS NIH HHS T32 AR007603-15
6 · The paper itself

Abstract

unlabelledIn establishing a respiratory infection, vaccinia virus (VACV) initially replicates in airway epithelial cells before spreading to secondary sites of infection, mainly the draining lymph nodes, spleen, gastrointestinal tract, and reproductive organs. We recently reported that interferon gamma (IFN-γ) produced by CD8 T cells ultimately controls this disseminated infection, but the relative contribution of IFN-γ early in infection is unknown. Investigating the role of innate immune cells, we found that the frequency of natural killer (NK) cells in the lung increased dramatically between days 1 and 4 postinfection with VACV. Lung NK cells displayed an activated cell surface phenotype and were the primary source of IFN-γ prior to the arrival of CD8 T cells. In the presence of an intact CD8 T cell compartment, depletion of NK cells resulted in increased lung viral load at the time of peak disease severity but had no effect on eventual viral clearance, disease symptoms, or survival. In sharp contrast, RAG(-/-) mice devoid of T cells failed to control VACV and succumbed to infection despite a marked increase in NK cells in the lung. Supporting an innate immune role for NK cell-derived IFN-γ, we found that NK cell-depleted or IFN-γ-depleted RAG(-/-) mice displayed increased lung VACV titers and dissemination to ovaries and a significantly shorter mean time to death compared to untreated NK cell-competent RAG(-/-) controls. Together, these findings demonstrate a role for IFN-γ in aspects of both the innate and adaptive immune response to VACV and highlight the importance of NK cells in T cell-independent control of VACV in the respiratory tract. IMPORTANCE: Herein, we provide the first systematic evaluation of natural killer (NK) cell function in the lung after infection with vaccinia virus, a member of the Poxviridae family. The respiratory tract is an important mucosal site for entry of many human pathogens, including poxviruses, but precisely how our immune system defends the lung against these invaders remains unclear. Natural killer cells are a type of cytotoxic lymphocyte and part of our innate immune system. In recent years, NK cells have received increasing levels of attention following the discovery that different tissues contain specific subsets of NK cells with distinctive phenotypes and function. They are abundant in the lung, but their role in defense against respiratory viruses is poorly understood. What this study demonstrates is that NK cells are recruited, activated, and contribute to protection of the lung during a severe respiratory infection with vaccinia virus.

Indexed as

AnimalsCD8-Positive T-LymphocytesFemaleInterferon-gammaKiller Cells, NaturalLungLymphocyte DepletionMice, Inbred C57BLMice, KnockoutOvaryRespiratory Tract InfectionsSurvival AnalysisVacciniaVaccinia virusViral LoadInterferon-gamma

Identifiers

PMID26468539
PMCPMC4702563
OpenAlexW2304991246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.